| A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from Latency EL Poole, VG Kew, JCH Lau, MJ Murray, T Stamminger, JH Sinclair, ... Cell reports 24 (3), 594-606, 2018 | 41 | 2018 |
| Characterisation of B. 1.1. 7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2 SJ Dicken, MJ Murray, LG Thorne, AK Reuschl, C Forrest, ... bioRxiv, 2021 | 31 | 2021 |
| Downregulation of the Central Noradrenergic System by Toxoplasma gondii Infection I Alsaady, E Tedford, M Alsaad, G Bristow, S Kohli, M Murray, M Reeves, ... Infection and Immunity 87 (2), 10.1128/iai. 00789-18, 2019 | 31 | 2019 |
| Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay MJ Murray, M McIntosh, C Atkinson, T Mahungu, E Wright, W Chatterton, ... Journal of Infection 82 (5), 170-177, 2021 | 30 | 2021 |
| Validation of immune cell modules in multicellular transcriptomic data G Pollara, MJ Murray, JM Heather, R Byng-Maddick, N Guppy, M Ellis, ... PloS one 12 (1), e0169271, 2017 | 30 | 2017 |
| Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection MJ Murray, NE Peters, MB Reeves Pathogens 7 (1), 30, 2018 | 29 | 2018 |
| Evolutionary remodelling of N‐terminal domain loops fine‐tunes SARS‐CoV‐2 spike D Cantoni, MJ Murray, MD Kalemera, SJ Dicken, L Stejskal, G Brown, ... EMBO reports 23 (10), e54322, 2022 | 23 | 2022 |
| High-throughput screening of a GlaxoSmithKline protein kinase inhibitor set identifies an inhibitor of human cytomegalovirus replication that prevents CREB and histone H3 post … AS Khan, MJ Murray, CMK Ho, WJ Zuercher, MB Reeves, BL Strang Journal of General Virology 98 (4), 754-768, 2017 | 16 | 2017 |
| Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads S Verfuerth, PSE Sousa, L Beloki, M Murray, MD Peters, S Mackinnon, ... Bone marrow transplantation 50 (10), 1358-1364, 2015 | 12 | 2015 |
| Evasion of a human cytomegalovirus entry inhibitor with potent cysteine reactivity is concomitant with the utilization of a heparan sulfate proteoglycan-independent route of entry MJ Murray, NI Bonilla-Medrano, QL Lee, SJ Oxenford, R Angell, ... Journal of Virology 94 (7), 10.1128/jvi. 02012-19, 2020 | 6 | 2020 |
| Are the patterns of cytomegalovirus viral load seen after solid organ transplantation affected by circadian rhythm? H Rafferty, MJ Murray, JCH Tam, A Macfarlane, C Smith, SF Lumley, ... The Journal of Infectious Diseases, 2022 | 2 | 2022 |
| In silico interrogation of the miRNAome of infected hematopoietic cells to predict processes important for human cytomegalovirus latent infection MJ Murray, E Bradley, Y Ng, O Thomas, K Patel, C Angus, C Atkinson, ... Journal of Biological Chemistry 299 (6), 2023 | | 2023 |
| Dissecting the initial events of human cytomegalovirus cell entry MJ Murray UCL (University College London), 2019 | | 2019 |
| Type I interferon activity promotes a cellular environment that supports the establishment of latency by human cytomegalovirus P Olaizola-Rebe, C Onyerindu, K Kiesworo, M Lodha, T Stamminger, ... Access Microbiology 1 (1A), 488, 2019 | | 2019 |
| Modular deconvolution of tissue transcriptomes: pitfalls and solutions G Pollara, MJ Murray, J Heather, BM Chain, M Noursadeghi The Lancet 387, S83, 2016 | | 2016 |
